drug protocol number

16691

drug sponsor

Bayer

drug study

Xarelto

drug trial site

Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh)

drug status

Ongoing

drug phase